Decision: Favourable

Decisions Table

Study Title:

A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 as a Monotherapy and in Combination in Participants with Aggressive and Indolent B-cell Malignancies

  • NREC Code:

    22-NREC-CT-136

  • Decision:

    Favourable

  • Meeting Date:

    17/08/2022

  • Study Type:

    NREC CT

  • Principal Investigator:

    Prof Elisabeth Vandenberghe

  • PI Institution:

    St James's Hospital

  • Sponsor:

    Labcorp Clinical Development Limited

Scroll to Top